Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study

Patricia Echeverría; Anna Bonjoch; Jordi Puig; José Moltó; Roger Paredes; Guillem Sirera; Arelly Ornelas; Nuria Pérez-Álvarez; Bonaventura Clotet; Eugènia Negredo

doi:10.1371/journal.pone.0084676

Loading metrics

Open Access

Peer-reviewed

Research Article

Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study

Patricia Echeverría ,

* E-mail: pecheverria@flsida.org

Affiliation Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain
⨯
Anna Bonjoch,

Affiliation Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain
⨯
Jordi Puig,

Affiliation Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain
⨯
José Moltó,

Affiliation Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain
⨯
Roger Paredes,

Affiliations Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain, IrsiCaixa AIDS Research Institute-HIVACAT, Barcelona, Spain
⨯
Guillem Sirera,

Affiliation Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain
⨯
Arelly Ornelas,

Affiliation Department of Econometrics, Statistics and Spanish Economy; University of Barcelona, Barcelona, Spain
⨯
Nuria Pérez-Álvarez,

Affiliations Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain, Statistics and Operations Research Department, Universitat Politècnica de Catalunya, Barcelona, Spain
⨯
Bonaventura Clotet,

Affiliations Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain, IrsiCaixa AIDS Research Institute-HIVACAT, Barcelona, Spain
⨯
Eugènia Negredo

Affiliation Department of HIV, Lluita contra la Sida Foundation, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Barcelona, Spain
⨯

Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study

Patricia Echeverría,
Anna Bonjoch,
Jordi Puig,
José Moltó,
Roger Paredes,
Guillem Sirera,
Arelly Ornelas,
Nuria Pérez-Álvarez,
Bonaventura Clotet,
Eugènia Negredo

Published: February 4, 2014
https://doi.org/10.1371/journal.pone.0084676

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cholesterol
Is the Subject Area "Cholesterol" applicable to this article?

Thanks for your feedback.
Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Antiretrovirals
Is the Subject Area "Antiretrovirals" applicable to this article?

Thanks for your feedback.
Lipid profiles
Is the Subject Area "Lipid profiles" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
HIV-1
Is the Subject Area "HIV-1" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.